Divided by an Ocean: How US and EU Cosmetic Regulations Treat Formaldehyde Differently — and What That Means for American Shoppers

Two Markets, One Molecule, Very Different Rules

Walk into a pharmacy in Paris and pick up a bottle of nail hardener or a moisturizing lotion. Chances are, the formulation you're holding has been scrutinized under one of the world's most stringent cosmetic regulatory frameworks. Cross the Atlantic to a drugstore in Chicago or Houston, and the product sitting on a nearly identical shelf may contain compounds that European manufacturers have been legally prohibited from using for years.

This is not a hypothetical gap. It is an ongoing, documented divergence in how two of the world's largest consumer markets have chosen to evaluate the same body of scientific evidence — and it has real consequences for the tens of millions of Americans who apply cosmetics and personal care products to their skin every day.

At the center of this divide is formaldehyde: a compound so chemically fundamental that the human body produces it naturally through normal metabolic processes, yet one that carries well-established risks at elevated concentrations, including sensitization, allergic contact dermatitis, and — at occupational exposure levels — links to certain cancers.

What the EU Has Restricted and Why

The European Union regulates cosmetic products under Regulation (EC) No 1223/2009, a framework that places the burden of proof squarely on manufacturers to demonstrate safety before products reach consumers. Under this system, the EU's Scientific Committee on Consumer Safety (SCCS) has progressively tightened restrictions on formaldehyde and a broad class of compounds known as formaldehyde-releasing preservatives — ingredients that do not contain free formaldehyde at the time of manufacture but gradually hydrolyze to release it once a product is in use.

As of recent regulatory updates, the EU has imposed strict concentration limits on formaldehyde in cosmetics, requiring warning labels when concentrations exceed 0.05 percent, and has outright banned its use in certain product categories, including nail hardeners sold to the general public above threshold concentrations. Several formaldehyde releasers — including DMDM hydantoin, imidazolidinyl urea, diazolidinyl urea, and quaternium-15 — face increasingly tight restrictions, with quaternium-15 having been effectively phased out in many European formulations.

The rationale is rooted in a precautionary interpretation of the available toxicological data. European regulators have leaned toward minimizing cumulative dermal exposure to formaldehyde across all sources, reasoning that consumers use multiple products simultaneously and that aggregate exposure may exceed safe thresholds even when individual products appear compliant.

How the US System Operates Differently

In the United States, cosmetics are regulated primarily under the Federal Food, Drug, and Cosmetic Act (FD&C Act), with the Food and Drug Administration (FDA) holding oversight authority. However, a fundamental structural difference distinguishes the US approach from the EU model: American cosmetics do not require pre-market approval. Manufacturers are largely responsible for assessing the safety of their own formulations before placing them on the market.

The FDA does maintain a list of prohibited and restricted ingredients, and it has the authority to take action against unsafe products after they reach consumers. But the agency has historically lacked both the statutory authority and the resources to conduct the kind of proactive, systematic ingredient review that characterizes European regulation.

Formaldehyde itself is not banned in US cosmetics. Formaldehyde-releasing preservatives remain widely used across product categories ranging from shampoos and conditioners to liquid soaps, baby washes, and skin creams. The Cosmetic Ingredient Review (CIR), an industry-funded expert panel that evaluates ingredient safety in the US context, has generally concluded that these compounds are safe at concentrations typically used in cosmetic formulations — a position that diverges from the more precautionary stance adopted across the Atlantic.

It is worth noting that the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, represents the most significant update to US cosmetic oversight in decades. MoCRA introduces new requirements for facility registration, product listing, safety substantiation documentation, and adverse event reporting. Whether this legislative shift will eventually translate into more proactive ingredient restrictions — including those affecting formaldehyde releasers — remains an open question.

The Science Behind the Disagreement

The regulatory divergence between the US and EU is not simply a matter of bureaucratic philosophy. It reflects a genuine scientific debate about how to interpret incomplete and sometimes conflicting data.

Dermal absorption of formaldehyde released from cosmetic preservatives is relatively limited compared to inhalation exposure. The skin metabolizes a significant portion of any formaldehyde it encounters before systemic absorption occurs. For most healthy adults using products at typical concentrations, acute toxicity is not a primary concern.

The more contested question involves sensitization. Formaldehyde is a recognized skin sensitizer, meaning that repeated exposure can trigger an immune response that manifests as allergic contact dermatitis — a condition that, once established, can be triggered by even trace exposures. Studies examining patch-test populations have consistently identified formaldehyde and formaldehyde releasers among the more common allergens detected in people presenting with contact dermatitis.

Cosmetic chemists who work across both regulatory environments note that the core disagreement often centers on cumulative risk modeling. European regulators have been more willing to apply conservative safety margins that account for simultaneous use of multiple products, while US assessments have tended to evaluate individual product concentrations in relative isolation.

What Consumers Can Actually Do

For American shoppers who want to limit their exposure to formaldehyde and its chemical relatives in personal care products, the path forward requires some label literacy. US cosmetic manufacturers are required to list ingredients in descending order of concentration, which means formaldehyde-releasing preservatives will appear on the ingredient panel — provided consumers know what to look for.

Key ingredients to identify include DMDM hydantoin, imidazolidinyl urea, diazolidinyl urea, quaternium-15, bronopol (2-bromo-2-nitropropane-1,3-diol), and sodium hydroxymethylglycinate. Each of these compounds releases formaldehyde as part of its preservative mechanism. Consumers with sensitive skin, a history of contact dermatitis, or known formaldehyde sensitivity may wish to prioritize products that use alternative preservation systems.

It is also worth acknowledging that preservation matters. Cosmetics that lack effective antimicrobial agents can become contaminated with bacteria and mold — hazards that carry their own health risks. The industry's gradual shift toward alternative preservative systems, including ethylhexylglycerin, caprylyl glycol, and certain plant-derived antimicrobials, reflects ongoing reformulation efforts, though not all alternatives have equivalent efficacy across product types.

A Regulatory Gap That Invites Scrutiny

The formaldehyde question in US cosmetics ultimately reflects a broader tension in American consumer product regulation: the balance between market access, innovation, and precautionary protection. The EU's approach prioritizes minimizing theoretical risk even in the absence of definitive harm data. The US approach has historically prioritized post-market evidence of actual harm before imposing restrictions.

Neither framework is without trade-offs. But as MoCRA begins to take effect and the FDA develops new guidance under its expanded authority, the conversation about where American cosmetic safety standards should sit relative to international benchmarks is one that regulators, manufacturers, and consumers will increasingly need to have — with formaldehyde chemistry squarely on the table.